Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Belatacept is a drug prescribed after kidney transplants. This drug temporarily suppresses the immune system so that the body won’t view the new kidney as a foreign invader and attempt to attack it.
Warnings/Side Effects
All immunosuppressive drugs put patients at risk of developing infections and illnesses because the immune system is disabled in order to accommodate the new organ. In the case of Belatacept, patients are at particular risk of developing Epstein-Barr virus. This virus can lead to mononucleosis or other illnesses. It stays in the patient’s immune system for the rest of his or her life, so patients who have suffered from mono or related illnesses should not take this drug.
There is also an increased risk of developing post-transplant lymphoproliferative disorder as a result of taking this drug. This is a disorder where the body develops too many white blood cells. This condition can lead to cancer of the central nervous system.
Finally, this medication should be used only for kidney transplants, not liver transplants. There is an increased risk of death when used in conjunction with liver transplants.
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.